Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04144751 · ClinicalTrials.gov registry record
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 23,494
- Enrollment target
NCT04144751 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 23,494 participants.
The verdict
NCT04144751 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 23,494 participants
- Enrollment target
Study Summary
The primary objective of this sub-study, 2019-01B, is to collect blood specimens for research use in the development and validation of a blood-based test for colorectal cancer (CRC).
Interventions
- OTHER Blood Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,494 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2023-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04144751
The ClinicalTrials.gov registry entry for NCT04144751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23,494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT04144751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04144751 about?
NCT04144751 is a clinical study titled "Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"". The primary objective of this sub-study, 2019-01B, is to collect blood specimens for research use in the development and validation of a blood-based test for colorectal cancer (CRC).
What is the current status of trial NCT04144751?
This trial is currently completed. The enrollment target is 23,494 participants. The study started on 2019-11-15. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04144751?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT04144751?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.